1700649360

1700649361 关于线粒体、抗逆转录病毒疗法与脂肪萎缩的关联，详见：“Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection，” Antiviral Therapy 13（2008）.

1700649362

1700649363 17 抓住时机

1700649364

1700649365 所有引述与利西耶维兹博士的相关背景信息，皆来自个人访谈。

1700649366

1700649367 关于信使RNA如何进行转译，详见：The Cell：A Molecular Approach ，2nd edition，by Geoffrey Cooper（Sinauer Associates，2000）.

1700649368

1700649369 由利西耶维兹开创的基因疗法，可详见她的论文：“Gene therapy approaches to HIV infection，” American Journal of Pharmacogenomics 2（2002）.

1700649370

1700649371 关于利西耶维兹与洛里的研究机构的更多信息，详见RIGHT网站：http：//www.rightinstitute.net.

1700649372

1700649373 18 移植手术

1700649374

1700649375 一篇关于哪位AML患者应当进行骨髓干细胞移植，以及原因为何的回顾：“Who should be transplanted for AML？” Leukemia 15（2001）.

1700649376

1700649377 关于AML患者在二次移植后的低存活率数据，详见：“Prognosis of patients with a second relapse of acute myeloid leukemia，” Leukemia 14（2000）. 关于AML复发的成年人患者的5年存活率仅有11%，详见：“Prognostic index for adult patients with acute myeloid leukemia in first relapse，” American Society of Clinical Oncology 23（2005）.

1700649378

1700649379 关于调理疗程如何抑制AML移植患者的免疫系统，详见：“Myeloablative conditioning regimens for AML allografts：30 years later，” Bone Marrow Transplantation 32（2003）.

1700649380

1700649381 19 “我们可能已经消灭HIV”

1700649382

1700649383 关于临床医师如何应用的比例，详见：“CD4 percentage，CD4 number，and CD4：CD8 ratio in HIV infection：which to choose and how to use，” Journal of Acquired Immune Deficiency Syndromes 2（1989）.

1700649384

1700649385 西里西亚诺极具影响力的论文：“Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy，” Science 278（1997）.

1700649386

1700649387 关于血液中静止T细胞所占的比例及其与HIV的关联，详见：“Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells，” Nature 435（2005）.

1700649388

1700649389 关于淋巴结为HIV最适切的目标，详见：“Lymph node pathology of acquired immunodeficiency syndrome（AIDS），” Annals of Clinical and Laboratory Science 20（1990）.

1700649390

1700649391 福克斯的论文使他参与了两位柏林病人的治疗：“HIV in infected lymph nodes，” Nature 370（1994）.

1700649392

1700649393 关于淋巴结结构的破坏，详见：“Human immunodeficiency virus pathogenesis：insights from studies of lymphoid cells and tissues，” Clinical Infectious Disease 33（2001）.

1700649394

1700649395 自1996年起，沃克发表了数篇具影响力的论文，包括：“Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor，” Journal of Infectious Diseases 173（1996）；“T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones：analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant，” Journal of Experimental Medicine 183（1996）；“Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection，” AIDS Research and Human Retroviruses 12（1996）；“Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load，” Journal of Immunology 156（1996）；“Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes，” Journal of Virology 70（1996）.

1700649396

1700649397 关于HIV和干扰素-γ在ELISPOT中的交互作用，详见：“The role of IFN-[gamma] Elispot assay in HIV vaccine research，” Nature 4（2009）.

1700649398

1700649399 关于在HIV中使用ELISPOT的问题的争论，详见：“The role of IFN- Elispot assay in HIV research，” Nature Protocols 4（2009）.

1700649400

1700649401 20 无法振奋人心的康复

1700649402

1700649403 德国国内生产总值（GDP）回馈至社会福利的比例与美国相比较的数据，援引自：“What the European and American welfare states have in common and where they differ：facts and fiction in comparisons of the European Social Model and the United States，” Journal of European Social Policy 20（2010）.

1700649404

1700649405 2008年，逆转录病毒和机会性感染大会（CROI）上公布的抗病毒药物：新特兹（Selzentry），药名马拉维若（maraviroc），其多国多中心随机双盲临床试验（MOTIVATE）的试验结果，详见：“Efficacy and safety of maraviroc plus optimized background therapy in treatment-experienced patients infected with CCR5-tropic HIV-1：48-week combined analysis of the MOTIVATE studies，” Abstract #792，15th Conference on Retroviruses and Opportunisitic Infections，Boston，MA（2008）.

1700649406

1700649407 21 临床试验

1700649408

1700649409 沃克针对HIV急性感染期免疫反应的早期论文：“Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia，” Science 278（1997）.

[ 上一页 ]  [ :1.70064936e+09 ]  [ 下一页 ]